Position Statement AME e Linee Guida
Gestione del nodulo benigno della tiroide causa di sintomi locali
A cura di AME, AIT, AIMN, ANIED, CAPE, FADOI, SIAPEC-IAP, SIE, SIRM, SIUEC, SIUMB.
Pubblicata il 6 aprile 2022 sul sito del SNLG e liberamente accessibile
Radiofrequency Ablation and Related Ultrasound-Guided Ablation Technologies for Treatment of Benign and Malignant Thyroid Disease: An International Multidisciplinary Consensus Statement of the American Head and Neck Society Endocrine Surgery Section with the Asia Pacific Society of Thyroid Surgery, Associazione Medici Endocrinologi, British Association of Endocrine and Thyroid Surgeons, European Thyroid Association, Italian Society of Endocrine Surgery Units, Korean Society of Thyroid Radiology, Latin American Thyroid Society, and Thyroid Nodules Therapies Association.
Head Neck 2022, 44: 633-60.
Italian Association of Clinical Endocrinologists (AME) and International Chapter of Clinical Endocrinology (ICCE). Position statement for clinical practice: prolactin-secreting tumors
Eur J Endocrinol 2022, 186: P1-33 (free full text)
Versione italiana
Traduzione italiana e adattamento/contestualizzazione delle linee guida AACE (versione 2020, free full text)
Algoritmo 2019 diabete mellito 2
Obesità 2016
Dislipidemia 2017
Italian Association of Clinical Endocrinologists (AME) and Italian AACE Chapter Position Statement for Clinical Practice:
Acromegaly (free full text)
Part 1: Diagnostic and Clinical Issues
Part 2: Therapeutic Issues
Versione in italiano
Italian consensus on diagnosis and treatment of differentiated thyroid cancer: joint statements of six Italian societies. J Endocrinol Invest 2018, 41: 849–76.
Osteonecrosi delle ossa mascellari da bisfosfonati o denosumab: analisi del rischio e azioni cliniche. AME Raccomanda 1/2018
Italian Association of Clinical Endocrinologists (AME) and Italian Chapter of the American Association of Clinical Endocrinologists (AACE) Position Statement: Clinical Management of Vitamin D Deficiency in Adults. Nutrients 2018, 10, 546 (free full text)
Assessment of Response to Treatment and Follow-Up in Gastroenteropancreatic Neuroendocrine Neoplasms. Endocr Metab Immune Disord Drug Targets 2018, DOI: 10.2174/1871530318666171213145803 (free full text).
Linee guida per il trattamento integrato del diabete mellito (traduzione del documento AACE e adattamento italiano). 2015-2018
AIT, ADI, AGICO, AME, FeSIN, FIMMG, SIE, SIEDP, SIGO, SINU, SINUT, SIP, SISDCA. Uso di sale iodato in età adulta e in età pediatrica. 2017.
American Association of Clinical Endocrinologists, American College of Endocrinology, and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules – 2016 update. Endocr Pract 2016, 22 (suppl 1): 2-60 (free full text).
Italian Association of Clinical Endocrinologists Statement–Replacement Therapy for Primary Hypothyroidism: A Brief Guide for Clinical Practice. Endocr Pract 2016, 11: 1319–26.
Italian association of clinical endocrinologists (AME) position statement: drug therapy of osteoporosis. J Endocrinol Invest 2016, DOI: 10.1007/s40618-016-0434-8.
Position statement AME: terapia sostitutiva dell’ipotiroidismo primitivo
Italian expert position sulla terapia medica nella sindrome di Cushing (forme ACTH-dipendenti e ACTH-indipendenti)
Position statement AME-AMD su Tireopatie e Diabete. Endocrine 2015, 49: 339-52.
Italian Association of Clinical Endocrinologists (AME) position statement: a stepwise clinical approach to the diagnosis of gastroenteropancreatic neuroendocrine neoplasms. J Endocrinol Invest 2014, 37: 875-909 (free full text).
Linee guida sul trattamento del diabete mellito con micro-infusori insulinici (traduzione del documento AACE e adattamento italiano). 2014
Linee guida per il trattamento nutrizionale, metabolico e non chirurgico nella fase peri-operatoria del paziente sottoposto a chirurgia bariatrica (traduzione del documento AACE e adattamento italiano). 2013
Position statement su Iperparatiroidismo Primario. J Endocrinol Invest 2012, 35 (7 Suppl): 2-21.
Position statement su Incidentaloma surrenalico. Eur J Endocrinol 2011, 164: 851-70.
Position statement su Terapia del M. di Basedow (con AIT) 2011
Position statement su Ipertiroidismo e gravidanza (con AIT). J Endocrinol Invest 2011, 34: 225-31.
Position statement su Nodulo e tumore tiroideo in gravidanza (con AIT). J Endocrinol Invest 2010, 33: 579-86.
Position statement su Nodulo tiroideo (con AACE e ETA). J Endocrinol Invest 2010, 33 (5 Suppl): 1-50.
Position statement su Acromegalia. J Endocrinol Invest 2009, 32 (6 Suppl): 2-25.
Linee guida cliniche per la diagnosi e il trattamento della patologia nodulare tiroidea AME-AACE 2006.
{seog:disable}